Immune Therapies in Practice in 2026: Cellular Therapies, ADCs, Bispecifics and Beyond is a 1-day educational conference jointly sponsored by the Fred Hutchinson Cancer Center and Physicians’ Education Resource (PER®). The program focuses on the real-world integration of next-generation immune therapies—including cellular therapies, antibody-drug conjugates, bispecific antibodies, and emerging approaches—across select hematologic and solid tumors.
Expert faculty will address practical implementation, with a dedicated emphasis on operationalizing bispecific antibodies in community oncology settings. Clinical discussions will span breast, genitourinary, renal, melanoma, lymphoma, and multiple myeloma immunotherapies, featuring interactive, case-based dialogue to support evidence-based decision-making in everyday oncology practice.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians' Education Resource®, LLC and Fred Hutchinson Cancer Center. Physicians' Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 7.0 Contact Hours.
721 Pine St, Seattle, WA 98101